Middle East and Africa Adenosine Triphosphate Swab Test Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type, Application

The Middle East and Africa Adenosine Triphosphate (ATP) swab test market is expected to reach US$ 24.77 million by 2027 from US$ 14.19 million in 2019. The market is estimated to grow with a CAGR of 7.3% from 2020 to 2027. The growth of the market is attributed to some key driving factors such as rising prevalence of healthcare associated infections (HAI) and increasing emphasis on food safety. However, limitations of ATP swab tests are a major factor hindering the market growth.

The ATP test is the fast calculation by identification of adenosine triphosphate or ATP of aggressively developing microorganisms. ATP is a molecule in and near living cells that explicitly tests the organisms' biological production and well-being. Healthcare-associated infectious are caused while receiving treatment or therapies in healthcare facilities. These infections are related to surgical procedures and medical instruments used during operations. The rising prevalence of HAIs is one of the prominent factors driving the demand for adenosine triphosphate swab tests. For instance, according to a study published by the Centers for Disease Control and Prevention (CDC) in 2019, an estimated 1 in 31 hospital patients has some healthcare-associated infection. Such a substantial prevalence of healthcare-associated disorders is anticipated to positively impact the adoption of the ATP swab test, which would eventually drive the market. Also, the utilization of adenosine triphosphate is a significant indicator of cleanliness and sterilization in food & beverages. Hence, the rising incidence of foodborne diseases and food contamination is prominently expected to drive the ATP swab test market during the forecast period.

The COVID-19 outbreak pandemic is adversely affecting countries in Middle East and Africa. In the Middle East, the all-sanitization processes at hospitals, medical establishments, and high touch point surfaces in public places utilize Adenosine Triphosphate (ATP) Swab Test to confirm the surface is free from micro-organisms which will likely boost the market. However, the outrageous number of COVID cases has resulted in disruption in the supply chain due to a long period of lockdown, which can hamper the market's growth. Therefore, it is likely to harm the Adenosine Triphosphate (ATP) Swab Test market owing to the above mention points.

The Middle East and Africa Adenosine Triphosphate (ATP) Swab Test market, based on the type was segmented into free ATP test, microbial ATP test. in 2019, microbial ATP test segment held the largest share of the market, and the same segment is expected to grow at the fastest rate during the coming year.

The Middle East and Africa Adenosine Triphosphate (ATP) Swab Test market, based on the application was segmented into pharmaceutical & biotechnology company, food & beverage, hospitals & diagnostics laboratories, and academic & research institutions. In 2019, pharmaceutical and biotechnology company held the largest share of the market. Moreover, the same segment is expected to grow at the fastest rate during the coming year.

A Few of the primary and secondary sources associated with this report on the Middle East and Africa Adenosine Triphosphate (ATP) swab test market are the Saudi Forum for Hospital Sterilization Services (SFHSS), Dubai Future Foundation (DFF) and Cooperative Council of Health Insurance (CCHI).